Lactobacillus reuteri MAK02L14R and Increased Duodenal B-Lymphocyte Counts

• Colonization and Immunomodulation by Lactobacillus reuteri ATCC 55730 in the Human Gastrointestinal Tract

  • 2004-02
  • Clinical Trial · n = 19
  • Applied and Environmental Microbiology 70(2)
  • • N. Valeur
    • P. Engel
    • N. Carbajal
    • E. Connolly
    • K. Ladefoged

  • PubMed: 14766603
  • DOI: 10.1128/AEM.70.2.1176-1181.2004

  8 Insights on

  • Increased Duodenal B-Lymphocyte Counts

  • High evidence
  • Highly Cited
  • Clinical

  duodenal B-lymphocyte numbers were increased by L. reuteri ATCC 55730 administration.

  Effect

  Beneficial

  Effect size

  Moderate